About Adlego Biomedical
Adlego Biomedical is a company based in Uppsala (Sweden) founded in 2005 was acquired by Scantox in September 2022. Adlego Biomedical offers products and services including Webhosting, Domæner, Cloud Server, Virtual Server, and Betalingsløsning. Adlego Biomedical operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
- Headquarter Uppsala, Sweden
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name A/S Scannet
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Adlego Biomedical
Adlego Biomedical offers a comprehensive portfolio of products and services, including Webhosting, Domæner, Cloud Server, Virtual Server, and Betalingsløsning.
Provides online storage and management for websites.
Handles registration and maintenance of domain names.
Offers scalable servers for data storage and applications.
Delivers virtual computing environments for businesses.
Facilitates secure online payment processing systems.
Funding Insights of Adlego Biomedical
Investors in Adlego Biomedical
Adlego Biomedical has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Scantox and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Laboratory focused on providing pharmacology, toxicology, and histopathology services
|
Locked | Locked | Locked |
Investor details for Adlego Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adlego Biomedical
Investment portfolio details for Adlego Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Adlego Biomedical
Detailed financials for Adlego Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adlego Biomedical Comparisons
Peer comparison for Adlego Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adlego Biomedical
Adlego Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| Locked | Locked | Locked |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| Locked | Locked | Locked |
Animal models are supplied for in-vivo analytical services.
|
|
| Locked | Locked | Locked |
Preclinical contract research organization offering standard GLP and non-GLP services
|
Detailed competitors of Adlego Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adlego Biomedical
Complete news archive for Adlego Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adlego Biomedical
Adlego Biomedical was founded in 2005 and raised its 1st funding round 15 years after it was founded.
Adlego Biomedical is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Adlego Biomedical was founded in 2005 and is based in Uppsala, Sweden, within the biomedical sector. In vivo studies on safety, efficacy, metabolism, and pharmacokinetics of hit and lead compounds are conducted. Services encompass DMPK assessments, acute and repeated-dose toxicity evaluations, haematology, clinical chemistry, and histopathology analyses. Effect models for cancer and inflammation are utilized, alongside behavioural and biocompatibility testing, surgical procedures, and catheterization capabilities.
Adlego Biomedical's top competitors include GenOway, PsychoGenics and Alpha Genesis.
Adlego Biomedical offers Webhosting, Domæner, Cloud Server, Virtual Server, and Betalingsløsning.
Adlego Biomedical has 2 investors. Key investors include Scantox, and European Union.